Express Pharma

Glenmark Pharma, USA continues to expand its OTC portfolio with acquisition of approved ANDAs from Wockhardt 

Glenmark’s current portfolio consists of 175 products authorised for distribution in the US marketplace and 48 ANDAs pending approval with the US FDA

0